ProKidney Corp. PROK
1.60
(0.08)
(4.76%)
as of 25 Sep
- Market cap
- $514.0M
- P/E
- 0.0×
Follow PROK
| Dec '17 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | — | 0.00 | 0.00 |
P/S ratio |
— | — | — | — | — | 0.00 | 335.98 |
P/FCF ratio |
— | — | — | — | — | 0.00 | 0.00 |
P/Operating CF |
— | — | — | — | — | (6.85) | (9.23) |
P/B ratio |
— | — | — | — | — | 0.00 | 0.00 |
Price to Tangible BV |
— | — | — | — | — | 0.00 | 0.00 |
EV/Sales |
— | — | — | — | — | 0.00 | 34.37 |
EV/EBITDA |
— | — | — | — | — | 1.08 | 0.00 |
EV/Operating CF |
— | — | — | — | — | 1.52 | (0.26) |
EV/FCF |
— | — | — | — | — | 1.23 | (0.26) |
Quick Ratio |
— | — | 1.67 | 45.09 | 14.55 | 9.96 | 8.82 |
Current Ratio |
— | — | 2.21 | 46.42 | 14.94 | 10.93 | 9.13 |
Net Debt/EBITDA |
— | 0.00 | 0.39 | 3.27 | 2.46 | 2.01 | 1.70 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
— | 0.94 | 0.91 | 0.71 | 2.54 | 2.07 | 1.74 |
Capex/Depreciation |
— | (5.66) | (2.62) | (0.61) | (8.88) | (5.43) | 0.46 |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 0.00% | 0.00% | 20.20% | 3.22% | 5.83% | 6.88% | |
| — | 0.00% | (273.69%) | (38.70%) | (7.56%) | (14.20%) | (17.77%) | |
ROIC |
— | 0.00% | (541.65%) | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
— | 0.00% | (209.56%) | (21.41%) | (9.07%) | (15.22%) | (22.91%) |
Average Days of Receivables |
— | — | — | — | 0.00 | 11,752.04 | 460.64 |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 167,984.21% | 12,779.73% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 73,794.74% | 5,798.10% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 38,647.37% | 2,837.18% |
Graham Net Nets |
— | — | — | — | — | (6.29) | (3.55) |
Graham Number |
— | — | — | — | — | 12.00 | 9.40 |
Earnings Yield |
— | — | — | — | — | (37.28%) | (23.21%) |
Free Cash Flow Yield |
— | — | — | — | — | (94.19%) | (39.03%) |
Revenue per Share |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Operating CF per Share |
— | 0.00 | (0.82) | (1.25) | (1.46) | (1.29) | (0.90) |
Capex per Share |
— | 0.00 | (0.08) | (0.03) | (0.55) | (0.30) | 0.02 |
Free Cash Flow per Share |
— | 0.00 | (0.90) | (1.28) | (2.01) | (1.59) | (0.87) |
Cash per Share |
— | — | 0.33 | 7.97 | 5.88 | 3.66 | 2.02 |
Shareholders Equity per Share |
— | 0.00 | 0.44 | (17.82) | (17.88) | (10.16) | (7.55) |
Interest Debt per Share |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.00 | 0.44 | (17.82) | (17.88) | (10.16) | (7.55) |
Free Cash Flow |
— | (30.64) | (55.49) | (78.93) | (124.27) | (155.86) | (117.10) |
Working Capital |
— | — | 14.96 | 493.85 | 349.11 | 359.67 | 249.94 |
Capital Expenditures |
— | (5.46) | (5.19) | (1.85) | (34.20) | (29.51) | 3.02 |
Net Current Asset Value |
— | 0.00 | 13.89 | (1,109.89) | (1,149.80) | (1,040.14) | (1,066.09) |
EV/EBIT |
— | — | — | — | — | 1.05 | 0.00 |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 | 0.00 | 388.28 | (3.38) |
Net Profit Margin |
— | 0.00% | 0.00% | 0.00% | 0.00% | (80,507.89%) | (7,725.20%) |
Price to Operating Income |
— | — | — | — | — | 0.00 | 0.00 |
| Other line items | |||||||
Depreciation/Fixed assets |
— | 0.00 | 0.17 | 0.28 | 0.09 | 0.13 | 0.13 |
Cash ROIC |
— | 0.00% | (129.87%) | 14.48% | 17.86% | 26.48% | 23.12% |
Accounts Receivable Turnover |
— | — | — | — | — | 0.04 | 0.50 |
Accounts Payable Turnover |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | 0.00 | 0.00 | — | — | — |
Average Receivables |
— | — | — | — | — | 1.91 | 1.79 |
Average Payables |
— | — | — | 2.94 | 4.07 | 4.37 | 2.29 |
Average Assets |
— | 0.00 | 20.15 | 279.15 | 469.27 | 430.81 | 388.32 |
Average Common Equity |
— | — | — | (534.85) | (1,100.01) | (1,049.17) | (1,003.08) |
Columns are period end dates